When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
Syros Pharmaceuticals (SYRS) is a small cap, clinical stage pharmaceutical company. As such it carries all the risks and potentials to the category. Mainly, if its drugs fail to gain regulatory approval, it will turn out to be a bad investment. If one or more drugs gain regulatory approval, and that is followed by commercial success, then Syros could turn out to be an extraordinarily good investment.